Eu dossiers.xls

EU Dossiers with Product Supply tie-up
50+125, 100+125 mg orally disinetragting granules 75, 100 mg enteric coated tabs; 500 mg effervescent tabs Acetylsalicylic Acid+Paracetamol+Caffeine 10 Acetylsalicylic Acid+Paracetamol+Codeine 500+250 mg orally disintegrating granules 250mg/10ml concentrate for solution for inf.
125, 250, 500 mg/2ml solution for injection 125mg/ 5 ml, 250mg/ 5 ml suspension, powder 500+100, 1000+200, 2000+200 mg sterlie injection in vials 250, 500, 1000, 2000 mg Injection, powder (vial + diluent ampoule) 250+125, 500+250, 1000+500, 2000+1000 mg Injection, powder (vial + diluent) 40+0.005, 40+0.01 mg/ml solution for injection in 1.8 ml vials 7.5 mg/ml concentrate for infusion in vials 200+6, 400+12 µg dry powder inhaler (caps + device) Note: Products only offered for countries where 3rd party intellectual property rights are not infringed. However the ultimate responsibility lies exclusively
with the licensee.
EU Dossiers with Product Supply tie-up
50, 350 mg powder & solvent for solution for injection 600mg+400 IU, 1200+800 IU effervescent tabs 500mg+440 IU, 1000+880 IU effervescent granules 600mg+400 IU, 500+440 IU, 1000mg+880 IU chewable tabs 500mg+200 IU+65µg orally disintegrating granules 50mg/5ml, 150mg/15ml, 450mg/45ml Injection, solution 250, 500, 1000 mg powder for inj. (vial + diluent) 1000mg (IM, IV) 2000mg (only IV) powder & solvent for solution for injection 500, 1000, 2000 mg Injection, powder (vial + diluent amp) 500, 1000 mg IM; IV powder & solvent for solution for injection Sodium 100, 250, 500, 1000, 2000 mg Injection, powder (vial + diluent amp) 500, 1000, 2000 mg powder & solvent for solution for injection 250, 500, 750, 1000, 1500, 2000 mg Injection, powder (vial + diluent) 250, 750, 1500 mg powder & solvent for solution for inj./inf.
alcoholic 70% v/v cutaneous sol in 125ml, 250ml bottles aqueous cutaneos sol 2% w/v 10ml, 60ml (bottles & amps blow-fill-seal) 2mg/ml solution for injection in bottles of 100, 200 ml 2mg/ml (5, 10 ml), 5mg/ml (30ml) solution for inj.
150mg/ml (1, 2, 4, 6 ml) solution for inj.
500, 1000 mg powder & solvent for solution for injection 1mg Injection, powder (amps + diluent amps) 151 Codeine+Noscapin+D, L, N-Methylephedrine Note: Products only offered for countries where 3rd party intellectual property rights are not infringed. However the ultimate responsibility lies exclusively
with the licensee.
EU Dossiers with Product Supply tie-up
50mg/2ml solution for inj; concentrate for solution for inf.
25, 50, 100 mg e.c. tabs; 25, 50, 75 mg g.r. caps 25mg GR + 50mg SR caps; 25mg GR + 75mg SR caps 25mg/5ml, 50mg/10ml, 125mg/25ml injection, solution in vials 20/0.5, 80/2 mg/ml solution for injection 1.25mg/ml, 2.5mg/ml, 5mg/2ml glass amps.
20mg/10ml, 50mg/25ml, 50mg/50ml, 200mg/100ml sol. for inj.
0.5mg powder & solvent for solution for perfusion 20+90, 20+100, 30+125, 30+150 µg tabs; triphasic tabs Triphasic 25+180, 25+215, 25+250, 35+180, 35+215, 35+250 µg tabs 100mg/50ml, 200mg/100ml injection solution 25, 50, 75, 100 µg/ hr transdermal patch 100/50, 200/100, 400/200 mg/ml solution for infusion 100mg/50ml, 200mg/100ml Injection, solution 0.1 mg/ml (5ml, 10ml) solution for inj.
Note: Products only offered for countries where 3rd party intellectual property rights are not infringed. However the ultimate responsibility lies exclusively
with the licensee.
EU Dossiers with Product Supply tie-up
50, 100, 125, 250, 500 µg dry powder inhaler (caps + device) dry powder inhaler 12 µg (caps + device) 200, 1000, 2000 mg lyophilized powder for injection 200mg/5ml, 1000mg/5ml solution for injection 200+150 mg orally disintegrating granules 270 Heparin+Hydroxyethyl Salicylate+Menthol 271 Heparin+Hydroxyethyl Salicylate+Menthol 5000 IU+5000mg+500mg per 100g gel; 50000 IU+5000mg+500mg per 100g gel 50 mg SR caps; 100mg/ ml drops; 3.8g/ 100g gel 2mg/2ml, 6mg/6ml concentrate for infusion solution 5, 10 mg powder for solution for injection 5mg/5ml 10mg/10ml, 20mg/20ml Injection, solution 250+250, 500+500 mg powder & solvent for injection 40mg/2ml, 100mg/5ml solution for injection 100 mg/ 5ml solution for injection or concentrate for solution for infusion 31 mg effervescent tabs; 35 mg orally disintegrating granules Note: Products only offered for countries where 3rd party intellectual property rights are not infringed. However the ultimate responsibility lies exclusively
with the licensee.
EU Dossiers with Product Supply tie-up
2, 5, 25, 50, 100, 200 mg dispersible tabs 100 mg/ml concentrate for solution for infusion 5mg/ml solution for infusion (vials & bags) oral solution 25, 50, 100 µg/5ml, 100 ml bottles powder for oral solution 6.86, 10, 10.70, 13.125, 13.72 gm sachet 355 Magnesium+Potassium+L-Carnitine+Grape seed extract 300mg+2mg+1µg orally disintegrating granules 15mg/1.5ml injection solution in ampoules 1%, 2%, 3% solution for injection (cartridges) 10mg/ml, 50mg/5ml glass vial (flip off cap) 20, 40, 250 mg Injection, powder (amp + diluent amp) 40, 125, 500, 1000, 2000 mg Injection, powder in vials 5mg/5ml, 15mg/3ml, 50mg/10ml solution for injection Note: Products only offered for countries where 3rd party intellectual property rights are not infringed. However the ultimate responsibility lies exclusively
with the licensee.
EU Dossiers with Product Supply tie-up
1mg/5ml vials; 0.05mg/ml, 0.1mg/ml, 0.2mg/ml, 0.5mg/ml ampoules.
2.5, 5, 7.5, 10, 15, 20 mg oro disperible tabs 40mg powder and solvent for solution for infusion in vials 50mg/10ml, 100mg/20ml, 200mg/40ml Injection, solution 15, 30, 60, 90 mg/10ml injection solution 40 mg lyophlized powder for injection (glass vial) 10mg/ml i.v. solution for infusion (in glass vials) 500, 1000 mg tabs; 500, 1000 mg effervescent tabs 500+15 mg chewable tabs; 500+30 mg effervescent tabs 447 Paracetamol+Dextromethorphan+Phenylephrine 650+12.2, 1000+12.2 mg direct to mouth tabs 100mg/ 5ml Injection, solution (amps + diluent amps) 100mg/2ml, 250mg/5ml solution for inj.
2+0.25, 3+0.375, 4+0.5g powder & solvent for solution for injection Note: Products only offered for countries where 3rd party intellectual property rights are not infringed. However the ultimate responsibility lies exclusively
with the licensee.
EU Dossiers with Product Supply tie-up
150, 300 mg tabs; 75, 150, 300 mg effervescent tabs 1mg/3ml, 2mg/5ml, 5mg/10ml concentrate for infusion 1, 2, 5 mg lyoph powder for solution for inj./inf.
2mg/ml, 5mg/ml, 7.5mg/ml, 10mg/ml ampoules & vials 50, 100 µg effervescent tabs; 50, 100 µg orally disintegrating granules 524 Sodium Alginate+Sodium Bicarbonate+Calcium Carbonate 0.25, 3, 6 mg powder & solvent for solution for infusion 200, 400 mg powder for infusion (glass vials) 20 mg Injection, powder (vial + diluent amp) Note: Products only offered for countries where 3rd party intellectual property rights are not infringed. However the ultimate responsibility lies exclusively
with the licensee.
EU Dossiers with Product Supply tie-up
20 mg tabs; 40mg/ml solution for injection 50mg/2ml, 100mg/2ml solution for injection; 100mg/100ml infusion bottle 300mg/5ml solution for inhalation (ampoules blow-fill-seal) 500mg/5ml ampoules; 100mg/ml solution in vials 80+12.5, 160+12.5, 160+25, 320+12.5, 320+25 mg tabs Bromide 4, 10, 20 mg inj. powd. in vials (amps + diluent amps) 10mg/1ml, 50mg/5ml solution for injection in vials 616 Zinc+Histidine+Vitamin C+Citrusflavonoids 10+50+300+5 mg orally disintegrating granules 617 Zinc+Vit C+Citrusflavonoids+herbal extracts Note: Products only offered for countries where 3rd party intellectual property rights are not infringed. However the ultimate responsibility lies exclusively
with the licensee.

Source: http://www.targopharma.com/product_list.pdf

Pli cash collateral w c and author

CASH COLLATERAL Rosenberg, Musso & Weiner, L.L.P., Brooklyn, New York § 363. Use, sale, or lease of property (a) In this section, “cash collateral” means cash, negotiable instruments, documents of title, securities, deposit accounts, or other cash equivalents whenever acquired in which the estate and an entity other than the estate have an interest and includes the proceeds

Cr_conventionnalismes_23_11_2007.pdf

Programme de formation-recherche « La philosophie des sciences en Autriche et en France au XXème siècle: histoires croisées, héritages, réceptions et influences réciproques » Compte rendu du workshop des 23 et 24 novembre 2007 Les premières journées organisées les 23 et 24 novembre 2007 – dans le cadre du programme de formation-recherche « La philosophie des sciences en Aut

Copyright © 2009-2018 Drugs Today